non small cell lung cancer life expectancy stage 2
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
Ngày tải lên :
18/06/2014, 16:20
... 69 61 57 21 7 60
SCC 1 0 7 1 12 0
LCC 5 0 4 11 0
others 3 0 2 0 0
EGFR
exon 19 29 10 18 21 55 58 21
exon21 27 0 12 14 18 56 23
wild-type 22 51 29 29 6 145 167 16
IHC sensitivity
overall 92%
delE746-A750 ... in non- small- cell lung cancer. Clin Cancer Res 20 09,
15:3 023 -3 028 .
13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,
Travis WD: Lung adenocarcinoma: modification of the 20 04 ... anticancer agents. Nat Rev Cancer
20 10, 10 :24 1 -25 3.
2. Sharma SV, Bell DW, Settleman J, Haber DA: Epidermal growth factor
receptor mutations in lung cancer. Nat Rev Cancer 20 07, 7:169-181.
3. Kosaka...
- 8
- 798
- 0
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx
Ngày tải lên :
09/08/2014, 09:20
... of non- small- cell lung
cancer. Int J Radiat Oncol Biol Phys 20 02, 52: 3 82- 389.
16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy
in treatment of stage I non- small cell ... status
0 65 2 47 16
1 48 0 31 17
21 1074
Tumor size (mm)
Range (median) 12- 55 (27 ) 12, 14 15-34 (24 ) 31-55 (35)
Operability
Operable 40 2 27 11
Non- operable 84 0 58 26
Histology
Adenocarcinoma 66 2 46 ... phase II trial of medically inoperable stage I non- small- cell
lung cancer patients treated with stereotactic body radiotherapy. J Clin
Oncol 20 09, 27 : 329 0- 329 6.
6. Takeda A, Sanuki N, Kunieda E,...
- 7
- 297
- 0
Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx
Ngày tải lên :
09/08/2014, 09:20
... iotherapy, Oligometastases, Non- Small Cell Lung Cancer
Background
Non- small cell lung cancer (NSCLC) is the leading
cause of cancer mortality in the United States [1].
Patients with stage IV NSCLC typically ... April 20 11 Accepted: 30 June 20 11 Published: 30 June 20 11
References
1. Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 20 10. CA Cancer J Clin
20 10, 60(5) :27 7-300, Epub 20 10 Jul 7.
2. Greene ... Oncology 20 11, 6:80
http://www.ro-journal.com/content/6/1/80
Page 2 of 7
RESEARC H Open Access
Comparison of outcomes in patients with stage III
versus limited stage IV non- small cell lung cancer
Praveena...
- 7
- 368
- 0
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps
Ngày tải lên :
09/08/2014, 09:22
... scheme
None Minor None Minor
Spinal Cord Any point 18 > 18 to 22 25 > 25 to 28
Oesophagus 1 24 > 24 to 27 27 > 27 to 28 .5
Ipsilateral Brachial Plexus 1 24 > 24 to 26 27 > 27 to 29
Heart ... Deviation
None Minor None Minor None Minor None Minor
<1 .25 1 .25 –1.40 < 12 12 14 <65 65–75 <5 5–8 0 20
<1.15 1.15–1 .25 <9 9–11 <70 70–80 <6 6–10 20 –40
<1.10 1.10–1 .20 <6 ... body radiotherapy for stage I
non- small cell lung cancer. Radiother Oncol 20 07, 85: 429 -434.
39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-
eral primary lung cancers: the Indiana...
- 14
- 308
- 0
Báo cáo khoa học: " Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases" docx
Ngày tải lên :
09/08/2014, 10:21
... 101 520 24
months
22
28
FEV 1
[l/sec.]
0.5
1.0
1.5
2. 0
0
Ư
Ư
Ư
Ư
2. 0 (1.1-3.0
)
1.9 (0.9 -2. 7) 2. 0 (1.0 -2. 7) 2. 1 (1.0 -2. 7)
ÁÁ
Á
Á
Á
1.5 (1.0 -2. 9) 1.5 (0.9-3.0) 1.6 (0.7 -2. 7) 1.5 (1.1 -2. 2)
1.4 (1.0 -2. 1) ... 1996,
1 72: 489-495.
22 . Hayakawa K, Mitsuhashi N, Saito Y, et al.: Limited field irradiation
for medically inoperable patients with peripheral stage I
non- small cell lung cancer. Lung Cancer 1999, 26 :137-1 42.
23 . ... Cancer 1999, 26 :137-1 42.
23 . Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation in
early stage (T1-2N0) non- small cell lung cancer. Radiother
Oncol 1996, 41:41-44.
24 . Fowler JF, Tomé...
- 9
- 329
- 0
Báo cáo khoa học: " Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer" pot
Ngày tải lên :
09/08/2014, 10:21
...
(Gy)
ID2 acute
reaction
TED ID2 late
reaction
McGill 3.5 Gy 15 19 52. 5 59 59 68
Standard 2 Gy 2 Gy 39 53 78 78 59 78
Sunnybrook
13
4 Gy 12 16 48 56 56 67
Wales
14
2. 75 20 26 55 58 55 60
ID2 = ... inoperable, early stage, non- small cell lung
cancer (NSCLC) treated with hypofractionation.
Materials and methods: Stage T1-2N0 NSCLC patients were treated with hypofractionation
alone, 52. 5 Gy/15 fractions, ... November 20 06
Radiation Oncology 20 06, 1: 42 doi:10.1186/1748-717X-1- 42
Received: 14 August 20 06
Accepted: 01 November 20 06
This article is available from: http://www.ro-journal.com/content/1/1/ 42
â 20 06...
- 6
- 391
- 0
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx
Ngày tải lên :
18/06/2014, 15:20
... (OS) (B).
0 4 8 121 620 2 428 323 6404448 52
Weeks
0
0 .2
0.4
0.6
0.8
1
TTP
Patients Events (%)
Arm A 35 33 (94.3)
Arm B 34 32 (94.1)
A
0 4 8 12 16 20 24 28 32 36 40 44 48 52
Weeks
0
0 .2
0.4
0.6
0.8
1
Survival
Patients ... Estimating the world cancer
burden: Globocan 20 00. Int J Cancer 20 01, 94:153-156.
2. Non- small Cell Lung Cancer Collaborative Group: Chemotherapy
in non small cell lung cancer: a meta-analysis ... chemotherapy in
patients with advanced non- small cell lung cancer: a lung
cancer Galician group phase II study. Cancer Chemother Pharma-
col 20 07, 60: 725 -7 32.
20 . Binder D, Sailer V, Schweigert M,...
- 8
- 538
- 0
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot
Ngày tải lên :
18/06/2014, 16:20
... with
bevacizumab for non- small- cell lung cancer. N Engl J Med 20 06,
355 :25 42- 50.
21 . Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol
20 07, 18(Suppl 9):ix135-ix1 42.
22 . Scagliotti ... in
non- small cell lung cancer. Clin Cancer Res 20 08, 14: 522 0-7.
30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts of
hypoxic markers according to NSCLC histology. Lung Cancer ... Wedge* 24 3 73 190 61
Pneumonectomy 92 27 37 47
Pathological stage <0.001
I 157 47 190 71
II 136 41 61 51
IIIa 42 12 17 23
Tumor status <0.001
1 85 25 190 74
2 188 56 84 57
3 621 925 36
Nodal...
- 9
- 662
- 0
báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot
Ngày tải lên :
18/06/2014, 19:20
... A, Ward E, Thun MJ: Cancer
statistics, 20 03. CA Cancer J Clin 20 03, 53:5 -26 .
5. Busick NP, Fretz PC, Galvin JR, Peterson MW: Staging of small cell
and non- small cell lung cancer. University of ... Lilenbaum R: Chemothera-
peutic management of stage IV non- small cell lung cancer.
Chest 20 03, 123 :22 65-435.
Health and Quality of Life Outcomes 20 08, 6:84 http://www.hqlo.com/content/6/1/84
Page ... patients with non- small cell lung cancer
previously treated with chemotherapy. J Clin Oncol 20 04,
22 :1589-97.
28 . Hopwood P, Watkins J, Ellis P, Smith I: Clinical interpretation of
quality of life outcomes:...
- 15
- 397
- 0
Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx
Ngày tải lên :
08/08/2014, 17:20
...
advanced non- small- cell lung cancer previously treated with
platinum-containing chemotherapy regimens. The TAX 320
Non- Small Cell Lung Cancer Study Group. J Clin Oncol. 20 00;
18( 12) : 23 54- 62.
7. ... ZD1839) in non- small- cell lung can-
cer. Br J Cancer. 20 04; 91 (2) : 20 8- 12.
89. Bailey R, Kris M, Wolf M. Gefitinib (Iressa, ZD 1839) mono-
therapy for pretreated advanced non- small cell lung cancer ... gefitinib in non- small cell lung cancer
cell lines. Mol Cancer Res. 20 06; 4(8): 521 -8.
1 02. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to
classify non- small- cell lung cancer patients...
- 9
- 203
- 0
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx
Ngày tải lên :
09/08/2014, 03:21
... agent
docetaxel in a patient with advanced non small
cell lung cancer
Ferdinando Riccardi
1*
, Giuseppe Di Lorenzo
1
, Carlo Buonerba
1
, Guglielmo Monaco
2
, Roberto Monaco
3
,
Mimma Rizzo
1
, Sarah ... treatment.
Introduction
In non- small cell lung cancer (NSCLC), mediastinal
lymphnode involvement comprises a wide spectrum of
severity. In fact, while 9% of patients with IIIA-N2
NSCLC is candidate ... Carteni’
1
Abstract
Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC),
presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless,...
- 4
- 303
- 0
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot
Ngày tải lên :
09/08/2014, 08:23
... 7.09
0.0 02
V25 12. 96% (5.90 -26 .26 %)
= 12. 88, SD = 4. 42 = 20 .91, SD = 6.98
0.001
V30 10.00% (4.68 -21 .43%)
= 9. 72, SD = 3.45 = 15.69, SD = 6.00
0.008
V35 9. 92% (3.89-18.65%)
= 7.57, SD = 2. 86 = ... 11 .26 , SD = 2. 81 = 14.91, SD = 2. 91
0.001
NTCP 2. 33% (0.51-9.68%)
= 2. 51, SD = 1.73 = 5.94, SD = 2. 40
0.001
V5 58.73% ( 32. 89-97.65%)
= 58.43, SD = 16.57 = 69 .23 , SD = 12. 47
0.006
V10 42. 16% (25 .28 -83.34%)
... volume reduction for normal lung using intensity-
modulated radiotherapy for advanced -stage non- small- cell lung
cancer. Int J Radiat Oncol Biol Phys 20 04, 58: 125 8- 126 7.
21 . Yom SS, Liao Z, Liu HH,...
- 8
- 371
- 0
Báo cáo khoa học: " Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer" potx
Ngày tải lên :
09/08/2014, 09:22
... (IAEA)
consultants' meeting on elective nodal irradiation in lung
cancer: non- small cell lung cancer (NSCLC). Int J Radiat Oncol
Biol Phys 20 08, 72( 2):335-3 42.
6. Therasse P, Arbuck SG, Eisenhauer EA, Wanders ... (37)
Squamous cell carcinoma 39 (34)
Large cell carcinoma 3 (3)
Mixed 2 (2)
Non- small cell not otherwise specified 28 (24 )
Grade (%)
Well-differentiated 7 (6)
Moderately differentiated 12 (10)
Poorly ... Clin Oncol 20 05, 28 :597-6 02.
15. Chang JY, Liu HH, Komaki R: Intensity modulated radiation
therapy and proton radiotherapy for non- small cell lung can-
cer. Curr Oncol Rep 20 05, 7 :25 5-9.
16....
- 7
- 375
- 0
Báo cáo khoa học: " Evalution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC)" pptx
Ngày tải lên :
09/08/2014, 10:20
...
chemotherapy
Pat #1 48,8 T4 N2 IIIB Adeno Ca < 5 42. 2 2 66 DDP +
Navelbine
Pat #2 52, 6 T3 N3 IIIB Adeno Ca 12 60 2 66 DDP +
Navelbine
Pat #3 71,5 T4 N2 IIIB SSC < 5
(5 mm AP)
62. 1 2 70 DDP +
Navelbine
Pat ... SSC 14 109.1 2 62 DDP +
Navelbine
Pat #5 49,0 T2 N2 IIIA Adeno Ca 11 147 .2 2 66 DDP +
Navelbine
Pat #6 34,9 T4 N2 IIIB Adeno Ca < 5 160.1 2 70 DDP +
Navelbine
Pat #7 74 ,2 T4 N2 IIIB Adeno ... 169.3 2 66 DDP +
Navelbine
Pat #8 75 ,2 T4 N1 IIIA Adeno Ca < 5 20 2.9 2 66 DDP +
Navelbine
Pat #9 61,7 T3 N2 IIIA Undifferentiated
NSCLC
10 2 216.1 66 DDP +
Navelbine
Pat #10 82, 1 T4 N2 IIIB...
- 13
- 255
- 0
Báo cáo khoa học: " Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer" pps
Ngày tải lên :
09/08/2014, 10:21
... patients with inoperable non- small
cell lung cancer (EORTC 089 72- 229 73). Eur J Cancer 20 07,
43:114- 121 .
9. TNM Classification of malignant tumours New York, Wiley-Liss; 20 02.
10. Kwa SL, Lebesque ... chemoradiotherapy in
non- small cell lung cancer (Review). In The Cochrane Library Vol-
ume 1. Wiley; 20 05:1-37.
25 . Vokes EE: Optimal therapy for unresectable stage III non-
small- cell lung cancer. J Clin ... radiother-
apy and concurrent daily cisplatin chemotherapy for stage III
non- small- cell lung cancer. Am J Clin Oncol 20 05, 28 :21 7 -22 2.
44. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G,...
- 10
- 336
- 0
